First Aid Shot Therapy Completes $24M Series C Financing Round

First Aid Shot Therapy (F.A.S.T.), a Burlingame, CA-based consumer healthcare company focused on over-the-counter (OTC) medicine in liquid shot form (40ml / 1.35oz.), completed a $24m Series C financing round.

The round was led by Johnson & Johnson Innovation – JJDC, with participation from new investors Lumira Capital and existing investors Sofinnova Ventures, Redmile Group and HealthQuest Capital, among others.

The company intends to use the funds to expand its product portfolio.

Led by Mary Page Platerink, founder and CEO, First Aid Beverages (dba First Aid Shot Therapy) focuses on the development and commercialization of a comprehensive portfolio of OTC pharmaceutical products in liquid ‘shot’ (40ml / 1.35oz.) format including F.A.S.T. Pain, Hangover Relief, Heartburn and Cold Relief.
Since its launch, the company has achieved listing with grocery and convenience distributors including: McLane’s, AMI (Core-Mark) and United Grocers, and placement at retailers such as HEB, Kum & Go, Circle K Southwest, United Pacific, EZ Mart, Holiday, Tedeschi’s Food Stores, Schnucks and Safeway. In addition, retailers such as CVS, Rite Aid, and 7-Eleven have recently been added as retail partners.



Join the discussion